Deal worth an estimated $1.1 billion.
Regulator to make decision by year end.
Agreement could add to Novartis’ immuno-oncology pipeline.
A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Topics, ranging from the seven-days- a-week NHS to Brexit, were on the oncology panel’s agenda.